Viva Biotech
(OTC) VBIZF
Viva Biotech Financials at a Glance
Market Cap
$724.95M
Revenue (TTM)
$3.83B
Net Income (TTM)
$171.97M
EPS (TTM)
$0.01
P/E Ratio
30.66
Dividend
$0.00
Beta (Volatility)
-6.52 (Low)
Dividend
$0.00
Beta (Volatility)
-6.52 (Low)
Price
$0.34
Volume
100,000
Open
$0.34
Price
$0.34
Volume
100,000
Open
$0.34
Previous Close
$0.34
Daily Range
$0.34 - $0.34
52-Week Range
$0.18 - $0.43
Dividend
$0.00
Beta (Volatility)
-6.52 (Low)
Price
$0.34
Volume
100,000
Open
$0.34
Previous Close
$0.34
Daily Range
$0.34 - $0.34
52-Week Range
$0.18 - $0.43
VBIZF News
VBIZF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Viva Biotech
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
2,063
CEO
Chen Mao
Website
www.vivabiotech.comHeadquarters
Shanghai, 201318, CN
VBIZF Financials
Key Financial Metrics (TTM)
Gross Margin
37%
Operating Margin
12%
Net Income Margin
9%
Return on Equity
4%
Return on Capital
4%
Return on Assets
3%
Earnings Yield
3.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$724.95M
Shares Outstanding
2.11B
Volume
100.00K
Short Interest
0.00%
Avg. Volume
1.70K
Financials (TTM)
Gross Profit
$687.40M
Operating Income
$269.59M
EBITDA
$563.46M
Operating Cash Flow
$373.99M
Capital Expenditure
$191.67M
Free Cash Flow
$182.32M
Cash & ST Invst.
$941.58M
Total Debt
$1.28B
Viva Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$831.87M
-27.2%
Gross Profit
$339.43M
-16.4%
Gross Margin
40.80%
N/A
Market Cap
$724.95M
N/A
Market Cap/Employee
$351.41K
N/A
Employees
2,063
N/A
Net Income
$121.81M
+11924.2%
EBITDA
$214.64M
-5.9%
Quarterly Fundamentals
Net Cash
$251.77M
+86.3%
Accounts Receivable
$305.75M
-11.4%
Inventory
$317.07M
+14.3%
Long Term Debt
$552.58M
-10.7%
Short Term Debt
$603.64M
-73.6%
Return on Assets
2.50%
N/A
Return on Invested Capital
3.80%
N/A
Free Cash Flow
$55.00M
-74.5%
Operating Cash Flow
$129.82M
-59.1%